| ・ | Zou Y, Takano H, Mizukami M, Akazawa H, Qin Y, Toko H, Sakamoto M, Minamino T, Nagai T, Komuro I. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation 108: 748-753, 2003. |
| ・ | Zou Y, Zhu W, Sakamoto M, Qin Y, Akazawa H, Toko H, Mizukami M, Takeda N, Minamino T, Takano H, Nagai T, Nakai A, Komuro I. Heat shock transcription factor 1 protects cardiomyocytes from ischemia/reperfusion injury. Circulation 108: 3024-3030, 2003. |
| ・ | Takano H, Zou Y, Hasegawa H, Akazawa H, Nagai T, Komuro I. Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. Antioxidants and Redox Signaling 5: 789-794, 2003. |
| ・ | Iijima Y, Nagai T, Mizukami M, Matsuura K, Ogura T, Wada H, Toko H, Akazawa H, Takano H, Nakaya H, Komuro I. Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes. FASEB Journal 17: 1361-1363, 2003. |
| ・ | Takano H, Ohtsuka M, Akazawa H, Toko H, Harada M, Hasegawa H, Nagai T, Komuro I. Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Current Pharmaceutical Design 9: 1121-1127, 2003. |
| ・ | Kudoh S, Akazawa H, Takano H, Zou Y, Toko H, Nagai T, Komuro I.Stretch-modulation of second messengers: effects on cardiomyocyte iontransport. Progress in Biophysics and Molecular Biology 82: 57-66, 2003. |
| ・ | Hasegawa H, Yamamoto R, Takano H, Mizukami M, Asakawa M, Nagai T, Komuro I. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats. Journal of Molecular and Cellular Cardiology 35: 953-960, 2003. |
| ・ | Takano H, Hasegawa H, Nagai T, Komuro I. The role of PPARg-dependent pathway in the development of cardiac hypertrophy. Drugs of Today 39: 347-357, 2003. |
| ・ | Takano H, Hasegawa H, Nagai T, Komuro I. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies. Internal Medicine 42: 465-469, 2003. |
| ・ |
高野博之 心不全の病態生理. 心不全のNew Concept−分子生物学、発生工学から考えた病態生理 89-115, 2003. |
| ・ |
高野博之、小室一成 うっ血性心不全. 外来診療のすべて 272-273, 2003. |
| ・ |
高野博之、小室一成 シグナル伝達分子としてのラジカル. Annual Review 2003 循環器 13-17, 2003. |
| ・ |
高野博之、小室一成 心肥大と拡張. 朝倉書店 内科学 第8版 485-489, 2003. |
| ・ |
高野博之、小室一成 急性心筋梗塞に対する新たな治療法としてのサイトカイン療法. 実験治療 671: 54-58, 2003. |
| ・ |
高野博之 PPARg と心血管病. Heart View 7: 234-239, 2003. |